These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 1634763

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. IL-12 prevents tolerance induction with mouse thyroglobulin by priming pathogenic T cells in experimental autoimmune thyroiditis: role of IFN-gamma and the costimulatory molecules CD40l and CD28.
    Zhang W, Flynn JC, Kong YC.
    Cell Immunol; 2001 Feb 25; 208(1):52-61. PubMed ID: 11277619
    [Abstract] [Full Text] [Related]

  • 3. Distinctive modulation by IL-4 and IL-10 of the effector function of murine thyroglobulin-primed cells in "transfer-experimental autoimmune thyroiditis".
    Mignon-Godefroy K, Brazillet MP, Rott O, Charreire J.
    Cell Immunol; 1995 May 25; 162(2):171-7. PubMed ID: 7743543
    [Abstract] [Full Text] [Related]

  • 4. Characterization of resistance to murine experimental autoimmune thyroiditis: duration and afferent action of thyroglobulin- and TSH-induced suppression.
    Fuller BE, Okayasu I, Simon LL, Giraldo AA, Kong YM.
    Clin Immunol Immunopathol; 1993 Oct 25; 69(1):60-8. PubMed ID: 7691454
    [Abstract] [Full Text] [Related]

  • 5. Noninvolvement of IL-4 and IL-10 in tolerance induction to experimental autoimmune thyroiditis.
    Zhang W, Kong YC.
    Cell Immunol; 1998 Aug 01; 187(2):95-102. PubMed ID: 9732697
    [Abstract] [Full Text] [Related]

  • 6. Synergism between mouse thyroglobulin- and vaccination-induced suppressor mechanisms in murine experimental autoimmune thyroiditis.
    Nabozny GH, Flynn JC, Kong YC.
    Cell Immunol; 1991 Sep 01; 136(2):340-8. PubMed ID: 1831404
    [Abstract] [Full Text] [Related]

  • 7. Differential requirement for autoantibody-producing B cells for induction of lymphocytic versus granulomatous experimental autoimmune thyroiditis.
    Braley-Mullen H, Sharp GC, Kyriakos M.
    J Immunol; 1994 Jan 01; 152(1):307-14. PubMed ID: 8254200
    [Abstract] [Full Text] [Related]

  • 8. Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody.
    Morris GP, Kong YC.
    J Autoimmun; 2006 Feb 01; 26(1):24-31. PubMed ID: 16253477
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction of granulomatous experimental autoimmune thyroiditis in mice with in vitro activated effector T cells and anti-IFN-gamma antibody.
    Stull SJ, Sharp GC, Kyriakos M, Bickel JT, Braley-Mullen H.
    J Immunol; 1992 Sep 15; 149(6):2219-26. PubMed ID: 1517579
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A thyroxine-containing thyroglobulin peptide induces both lymphocytic and granulomatous forms of experimental autoimmune thyroiditis.
    Braley-Mullen H, Sharp GC.
    J Autoimmun; 1997 Dec 15; 10(6):531-40. PubMed ID: 9451592
    [Abstract] [Full Text] [Related]

  • 13. Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines.
    Tang H, Braley-Mullen H.
    Int Immunol; 1997 May 15; 9(5):679-87. PubMed ID: 9184913
    [Abstract] [Full Text] [Related]

  • 14. CD40L is necessary for the priming of effector cells for lymphocytic and granulomatous experimental autoimmune thyroiditis.
    Peterson KE, Braley-Mullen H.
    J Autoimmun; 1999 Feb 15; 12(1):1-12. PubMed ID: 10028017
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT). Evidence for IL-10-enhanced cell death in EAT.
    Mignon-Godefroy K, Rott O, Brazillet MP, Charreire J.
    J Immunol; 1995 Jun 15; 154(12):6634-43. PubMed ID: 7759896
    [Abstract] [Full Text] [Related]

  • 17. T cell receptor V beta usage in murine experimental autoimmune thyroiditis.
    McMurray RW, Hoffman RW, Tang H, Braley-Mullen H.
    Cell Immunol; 1996 Aug 25; 172(1):1-9. PubMed ID: 8806800
    [Abstract] [Full Text] [Related]

  • 18. Prospective study of T cell receptor utilization following the induction of murine thyroiditis.
    Nakashima M, Kong YM, Wan Q, Davies TF.
    Exp Clin Endocrinol Diabetes; 1996 Aug 25; 104 Suppl 4():46-51. PubMed ID: 8981001
    [Abstract] [Full Text] [Related]

  • 19. Suppression in murine experimental autoimmune thyroiditis: in vivo inhibition of CD4+ T cell-mediated resistance by a nondepleting rat CD4 monoclonal antibody.
    Nabozny GH, Cobbold SP, Waldmann H, Kong YC.
    Cell Immunol; 1991 Nov 25; 138(1):185-96. PubMed ID: 1680568
    [Abstract] [Full Text] [Related]

  • 20. Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis.
    Zhou JS, Gill HS.
    Int J Food Microbiol; 2005 Aug 15; 103(1):97-104. PubMed ID: 16084270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.